89Zr-huJ591 Immuno-Pet Imaging in Patients With Advanced Metastatic Prostate Cancer

European Journal of Nuclear Medicine and Molecular Imaging - Germany
doi 10.1007/s00259-014-2830-7
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

Imaging Metastatic Castration-Resistant Prostate Cancer Patients With 89Zr-Dfo-Mstp2109a Anti-Steap1 Antibody

Journal of Nuclear Medicine
MedicineNuclear MedicineRadiologyImaging
2019English

Immuno-Pet Imaging of 89Zr Labeled Anti-Pd-L1 Domain Antibody

English

[11c]-Choline PET/CT in Imaging Locally Advanced Prostate Cancer

Nuclear Medicine Review
MedicineNuclear MedicineRadiologyImaging
2011English

89Zr-Trastuzumab and 89Zr-Bevacizumab PET to Evaluate the Effect of the HSP90 Inhibitor NVP-AUY922 in Metastatic Breast Cancer Patients

Clinical Cancer Research
Cancer ResearchOncology
2014English

Clinical PET Imaging in Prostate Cancer

Radiographics
MedicineNuclear MedicineRadiologyImaging
2017English

89Zr-Onartuzumab PET Imaging of C-Met Receptor Dynamics

European Journal of Nuclear Medicine and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2017English

Molecular Imaging of Prostate Cancer With 18f-Fluorodeoxyglucose PET

Nature Reviews Urology
Urology
2009English

Prognostic Value of 18f-Fluorocholine PET Parameters in Metastatic Castrate-Resistant Prostate Cancer Patients Treated With Docetaxel

Contrast Media and Molecular Imaging
MedicineNuclear MedicineRadiologyImaging
2019English

Gallium 68 PSMA-11 PET/MR Imaging in Patients With Intermediate- Or High-Risk Prostate Cancer

Radiology
Nuclear MedicineRadiologyImaging
2018English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy